Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in sarcoidosis.

B Chang1, J Steimel, D R Moller

  • 1Department of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

American Journal of Respiratory and Critical Care Medicine
|February 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical implementation challenges of component-resolved diagnostics in allergy and countermeasures through continuing medical education].

Zhonghua yi xue za zhi·2026
Same author

[Multicenter component-resolved study of inhalant allergen sensitization and cross-reactivity in airway allergic patients].

Zhonghua yi xue za zhi·2026
Same author

[Primary SMARCA4-deficient triple-negative breast cancer: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
Same author

[Precise diagnosis of allergic diseases: construction of a clinical decision-making system based on epidemiology and quantitative IgE testing].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025
Same author

[Application analysis of clinical implementation and educational promotion of allergen testing in the standardization of diagnosis and treatment].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025
Same author

The effectiveness of personalised food choice advice tailored to an individual's socio-demographic, cognitive characteristics, and sensory preferences.

Appetite·2024
Same journal

Signal in the Noise: Polygenic Scores and the Problem of Defining Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same journal

Do mtDNA fragmentomic peaks reflect cancer biology or preanalytical and technical artifacts in NSCLC?

American journal of respiratory and critical care medicine·2026
Same journal

Short for Their Age: Interpreting Whole-Genome Telomere Length in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same journal

Association of a Polygenic Risk Score with Diagnosis and Outcomes in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same journal

Reply to Qu et al.: Do mtDNA fragmentomic peaks reflect cancer biology or preanalytical and technical artifacts in NSCLC?

American journal of respiratory and critical care medicine·2026
Same journal

How the Exposome Shapes Our Respiratory Health.

American journal of respiratory and critical care medicine·2026
See all related articles

Depression affects 60% of U.S. sarcoidosis patients, impacting their quality of life. Female sex, limited medical access, and breathing difficulties are key risk factors for depression in sarcoidosis.

Area of Science:

  • Pulmonary Medicine
  • Psychiatry
  • Epidemiology

Background:

  • Sarcoidosis is a chronic, multisystem inflammatory disease with significant impact on patient quality of life.
  • Depression is a common comorbidity in chronic illnesses, yet its prevalence in U.S. sarcoidosis patients remained unquantified.
  • This study aimed to determine depression prevalence and associated factors in a U.S. sarcoidosis cohort.

Discussion:

  • The high prevalence of depression (60%) underscores the need for integrated mental health screening and support within sarcoidosis care.
  • Factors such as female sex, reduced access to medical care, and increased dyspnea severity were significant predictors of depression.
  • Despite access to tertiary care, patients reported limitations in medical care, highlighting systemic barriers.

Key Insights:

Related Experiment Videos

  • Depression prevalence among U.S. sarcoidosis patients is 60%.
  • Female gender, limited access to healthcare, and dyspnea are significant predictors of depression.
  • Multisystem involvement in sarcoidosis correlates with increased depression risk.

Outlook:

  • Future research should focus on developing and evaluating targeted interventions for depression in sarcoidosis.
  • Healthcare providers need enhanced sensitivity to the barriers faced by sarcoidosis patients and should prioritize improving access to care.
  • Integrating depression screening and management into routine sarcoidosis care is crucial for improving patient outcomes.